Alzheimer's Disease
Alzheimer's disease is a progressive brain disorder that slowly destroys memory and thinking skills, eventually interfering with daily tasks. It is the most common cause of dementia among older adults.
We are studying whether a 30-week caffeine treatment can help improve thinking and memory in people with early to moderate Alzheimer's disease. This trial compares the effects of caffeine to a placebo to see if it makes a difference.
Health conditions and diseases that the clinical trial is designed to study and treat.
Alzheimer's disease is a progressive brain disorder that slowly destroys memory and thinking skills, eventually interfering with daily tasks. It is the most common cause of dementia among older adults.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.